Publikationen in Zusammenarbeit mit Forschern von Universitat de Barcelona (22)

2024

  1. Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine

    The Lancet Respiratory Medicine, Vol. 12, Núm. 4, pp. 305-322

2023

  1. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

2022

  1. Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study

    The European respiratory journal, Vol. 59, Núm. 2

  2. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients

    Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240

  3. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

  4. Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units

    Archivos de Bronconeumologia, Vol. 58, pp. 22-31

  5. N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study

    Clinical Microbiology and Infection, Vol. 28, Núm. 10, pp. 1391.e1-1391.e5

  6. One-year mortality after ICU admission due to COVID-19 infection

    Intensive Care Medicine

2021

  1. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients

    Translational Research, Vol. 236, pp. 147-159

  2. Combining immunomodulators and antivirals for COVID-19 – Authors' reply

    The Lancet Microbe

  3. Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma

    European Journal of Clinical Investigation, Vol. 51, Núm. 6

  4. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  5. Mounting evidence of impaired viral control in severe COVID-19

    The Lancet Microbe

  6. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

    The Lancet Respiratory Medicine, Vol. 9, Núm. 6, pp. 622-642

  7. The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients

    Critical Care, Vol. 25, Núm. 1

2020

  1. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction

    Cardiovascular research, Vol. 116, Núm. 10, pp. e132-e133

  2. Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection

    Journal of Infection

  3. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

    Critical Care, Vol. 24, Núm. 1

2019

  1. Lymphocytopenia as a predictor of mortality in patients with ICU-acquired pneumonia

    Journal of Clinical Medicine, Vol. 8, Núm. 6

2017

  1. Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality

    EBioMedicine, Vol. 24, pp. 231-236